Increase in drugs‐of‐abuse findings in post‐mortem toxicology due to COVID‐19 restrictions—First observations in Finland,Drug Testing and Analysis

当前位置： X-MOL 学术 › Drug Test. Anal. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Increase in drugs‐of‐abuse findings in post‐mortem toxicology due to COVID‐19 restrictions—First observations in Finland
Drug Testing and Analysis ( IF 2.6 ) Pub Date : 2020-11-20 , DOI: 10.1002/dta.2982
Claudia Mariottini ₁ , Ilkka Ojanperä _{1,

2} , Pirkko Kriikku _{1,

2}

Affiliation

A lot has been published on the anticipated effects of the current COVID‐19 pandemic on users of illegal drugs. In this study, we present evidence‐based data on such effects, namely, the increased number of drug findings in post‐mortem investigations. All post‐mortem toxicology cases positive for at least one of the following: buprenorphine, amphetamine or cannabis, were investigated in the first 8 months of the year 2020, and the monthly numbers were compared to those in the previous 5 years from 2015 to 2019. These substances served as indicator analytes that could reveal changes in the drug using population. Right after the government restrictions came into force in March 2020, the numbers of buprenorphine, amphetamine and cannabis findings increased. The increase was most noticeable for amphetamine and was evident in all age groups. Our findings indicate that the assumptions on the increased risk of drug‐related harm (including death) have become reality. Reduced access to harm‐reduction services seems to have increased the mortality among individuals that use buprenorphine, amphetamine or cannabis. Significant and prompt actions need to be taken in order to find new ways in helping this vulnerable group of people.

中文翻译：

由于COVID-19的限制，死后毒理学中滥用药物发现的增加-芬兰的首次观察

关于当前COVID-19大流行对非法药物使用者的预期影响，已经发表了很多文章。在这项研究中，我们提供了有关此类影响的循证数据，即验尸调查中发现的药物数量增加。在2020年的前8个月调查了至少下列其中一种阳性的所有死后毒理学病例：丁丙诺啡，苯丙胺或大麻，并将月数与2015年至2019年的前5年进行了比较这些物质用作指示性分析物，可以揭示人群中药物的变化。在政府限制措施于2020年3月生效后，丁丙诺啡，苯丙胺和大麻的发现数量有所增加。苯丙胺的增加最为明显，并且在所有年龄段均明显。我们的发现表明，关于与药物相关的危害（包括死亡）风险增加的假设已成为现实。减少使用减害服务的机会似乎增加了使用丁丙诺啡，苯丙胺或大麻的个体的死亡率。为了找到新方法来帮助这一弱势群体，需要采取重大而迅速的行动。

更新日期：2020-11-20

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11